We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Withdraws Several Guidances as Inconsistent With New cGMP Initiative
FDA Withdraws Several Guidances as Inconsistent With New cGMP Initiative
May 30, 2006
The FDA, in a notice to be published in the Federal Register June 1, will announce its plans to withdraw and revise seven guidances as inconsistent with its pharmaceutical current good manufacturing practices (cGMP) initiative.